These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Update on dyslipoproteinemias and their role in changes in the statoacoustic apparatus]. Pallestrini EA; Borasi F Ann Laringol Otol Rinol Faringol; 1978; 76(3):239-76. PubMed ID: 233339 [No Abstract] [Full Text] [Related]
6. Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease. Kostner GM; Wurm H; Zechner R; Pilger E; Dieplinger H Prog Clin Biol Res; 1985; 188():67-77. PubMed ID: 4059260 [No Abstract] [Full Text] [Related]
7. [Lipoprotein metabolism in the blood plasma and liver in alimentary dyslipoproteinemias in an experiment]. Liapkov BG Vopr Pitan; 1985; (5):32-7. PubMed ID: 4082518 [TBL] [Abstract][Full Text] [Related]
8. Classification of primary dyslipoproteinemias. Dargel R Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651 [No Abstract] [Full Text] [Related]
9. [Genetic studies in familial hyperlipoproteinemia, and therapeutic implications]. de Gennes JL Ann Biol Clin (Paris); 1988; 46(1):1-3. PubMed ID: 3389574 [No Abstract] [Full Text] [Related]
10. [Problems of the pathogenesis of arteriosclerosis from the position of modern biochemical research]. Klimov AN Kardiologiia; 1980 Aug; 20(8):5-11. PubMed ID: 7412097 [No Abstract] [Full Text] [Related]
12. The pathogenesis of hyperlipoproteinaemia. Shepherd J; Packard CJ Scott Med J; 1986 Jul; 31(3):154-61. PubMed ID: 3798078 [TBL] [Abstract][Full Text] [Related]
13. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias. Chait A Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in lipoprotein metabolism and the genetic dyslipoproteinemias. Brewer HB; Rader DJ; Hoeg JM; Mann A; Tennyson G Adv Exp Med Biol; 1991; 285():237-44. PubMed ID: 1830448 [TBL] [Abstract][Full Text] [Related]
15. [Lipoprotein receptors and dyslipoproteinemias]. Orbetsova V Vutr Boles; 1984; 23(3):1-7. PubMed ID: 6087571 [No Abstract] [Full Text] [Related]
16. Animal models for disorders of hepatic lipoprotein metabolism. Willnow TE; Herz J J Mol Med (Berl); 1995 May; 73(5):213-20. PubMed ID: 7670924 [TBL] [Abstract][Full Text] [Related]
17. Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis. Alaupovic P Ann Biol Clin (Paris); 1980; 38(2):83-93. PubMed ID: 6992659 [No Abstract] [Full Text] [Related]
18. Molecular variants of the lipoproteins. Galton DJ; Stocks J; Rees A Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583 [No Abstract] [Full Text] [Related]
19. Small genetic effects in complex diseases: a review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Hegele RA Clin Biochem; 1997 Apr; 30(3):183-8. PubMed ID: 9167893 [TBL] [Abstract][Full Text] [Related]
20. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors. Schonfeld G Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755 [No Abstract] [Full Text] [Related] [Next] [New Search]